Skip to main content
Erschienen in: Surgery Today 12/2015

01.12.2015 | Original Article

Probiotics inhibit immune fluctuation in the intestinal mucous layer in rats

verfasst von: Tian weijun, Zhang teng

Erschienen in: Surgery Today | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Innate lymphocytes play a key role in maintaining the immune bowel barrier, which provides resistance to infection. However, the effects of probiotics on changes in the function of innate lymphocytes in the postoperative intestine remain known.

Methods

Ninety-six male SD rats were divided into the blank group and the preoperative Lactobacillus intervention group, and parts of the ileum were sampled on days 0, 3, 5 and 7 after partial small bowel resection. Distal ileum samples were evaluated using immunohistochemistry to detect IL-5, IL-13, IL-17a and IL-22.

Results

(1) There were more immune cells in the experimental group than in the blank group on day. (2) After the first 3 days, the levels of IL-22 and IL-5 (p = 0.024) were higher in the experimental group than in the blank group. From the third to the fifth day, the IL-5 and IL-22 levels were higher and the IL-13 and IL-17A levels were lower in the experimental group than in the blank group. From the fifth to the seventh day, the IL-5 and IL-13 levels were lower and the IL-22 and IL17A levels were higher in the experimental group than in the blank group.

Conclusions

Probiotics stabilize the fluctuation of the intestinal immune system postoperatively.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Yang YM, Tian XD, Zhuang Y, Wang WM, Wan YL, Huang YT. Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol. 2005;11(16):2456–61.PubMedCentralCrossRefPubMed Yang YM, Tian XD, Zhuang Y, Wang WM, Wan YL, Huang YT. Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol. 2005;11(16):2456–61.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372–85.CrossRefPubMed Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39(2):372–85.CrossRefPubMed
3.
Zurück zum Zitat Rayes N, Hansen S, Seehofer D, Muller AR, Serke S, Bengmark S, et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition. 2002;18(7–8):609–15.CrossRefPubMed Rayes N, Hansen S, Seehofer D, Muller AR, Serke S, Bengmark S, et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition. 2002;18(7–8):609–15.CrossRefPubMed
4.
Zurück zum Zitat Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, Nussler NC, et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg. 2007;246(1):36–41.PubMedCentralCrossRefPubMed Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, Nussler NC, et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg. 2007;246(1):36–41.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244(5):706–14.PubMedCentralCrossRefPubMed Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244(5):706–14.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg. 1990;125(3):403–4.CrossRefPubMed Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg. 1990;125(3):403–4.CrossRefPubMed
8.
Zurück zum Zitat Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific Lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 2002;89(9):1103–7.CrossRefPubMed Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific Lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 2002;89(9):1103–7.CrossRefPubMed
9.
Zurück zum Zitat Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74(1):123–7.CrossRefPubMed Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74(1):123–7.CrossRefPubMed
10.
Zurück zum Zitat Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant. 2005;5(1):125–30.CrossRefPubMed Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant. 2005;5(1):125–30.CrossRefPubMed
11.
Zurück zum Zitat Anderson AD, McNaught CE, Jain PK, MacFie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut. 2004;53(2):241–5.PubMedCentralCrossRefPubMed Anderson AD, McNaught CE, Jain PK, MacFie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut. 2004;53(2):241–5.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat McNaught CE, Woodcock NP, MacFie J, Mitchell CJ. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut. 2002;51(6):827–31.PubMedCentralCrossRefPubMed McNaught CE, Woodcock NP, MacFie J, Mitchell CJ. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut. 2002;51(6):827–31.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat McNaught CE, Woodcock NP, Anderson AD, MacFie J. A prospective randomised trial of probiotics in critically ill patients. Clin Nutr. 2005;24(2):211–9.CrossRefPubMed McNaught CE, Woodcock NP, Anderson AD, MacFie J. A prospective randomised trial of probiotics in critically ill patients. Clin Nutr. 2005;24(2):211–9.CrossRefPubMed
14.
Zurück zum Zitat Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463(7280):540–4.CrossRefPubMed Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463(7280):540–4.CrossRefPubMed
15.
Zurück zum Zitat Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011;12(11):1045–54.PubMedCentralCrossRefPubMed Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011;12(11):1045–54.PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Kawanishi H, Joseph K. IL4, IL5 and IL6-mediated regulation of immunoglobulin (Ig) heavy chain class switching and Ig production by gut-associated lymphoid tissue (GALT) B cells from athymic nude (nu/nu) mice. Immunol Invest. 1991;20(7):605–21.CrossRefPubMed Kawanishi H, Joseph K. IL4, IL5 and IL6-mediated regulation of immunoglobulin (Ig) heavy chain class switching and Ig production by gut-associated lymphoid tissue (GALT) B cells from athymic nude (nu/nu) mice. Immunol Invest. 1991;20(7):605–21.CrossRefPubMed
17.
Zurück zum Zitat Tan Y, Li Y, Liu D, Zhong L. Suplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA3/IL5 signaling pathway in asthmatic rats. Mol Med Rep. 2013;8(1):161–7.PubMed Tan Y, Li Y, Liu D, Zhong L. Suplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA3/IL5 signaling pathway in asthmatic rats. Mol Med Rep. 2013;8(1):161–7.PubMed
18.
Zurück zum Zitat Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012;30:647–75.CrossRefPubMed Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012;30:647–75.CrossRefPubMed
19.
Zurück zum Zitat Sonnenberg GF, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity. 2012;37(4):601–10.PubMedCentralCrossRefPubMed Sonnenberg GF, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity. 2012;37(4):601–10.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Sartor RB. The intestinal microbiota in inflammatory bowel diseases. Nestle Nutr Inst Workshop Ser. 2014;79:29–39.CrossRefPubMed Sartor RB. The intestinal microbiota in inflammatory bowel diseases. Nestle Nutr Inst Workshop Ser. 2014;79:29–39.CrossRefPubMed
21.
Zurück zum Zitat Coşkun Cevher Ş, Balabanli B, Aslim B. Effects of probiotic supplementation on systemic and intestinal oxidant–antioxidant events in splenectomized rats. Surg Today. 2014. doi:10.1007/s00595-014-1035-9. Coşkun Cevher Ş, Balabanli B, Aslim B. Effects of probiotic supplementation on systemic and intestinal oxidant–antioxidant events in splenectomized rats. Surg Today. 2014. doi:10.​1007/​s00595-014-1035-9.
22.
Zurück zum Zitat Ovington KS, McKie K, Matthaei KI, Young IG, Behm CA. Regulation of primary Strongyloides ratti infections in mice: a role for interleukin-5. Immunology. 1998;95(3):488–93.PubMedCentralCrossRefPubMed Ovington KS, McKie K, Matthaei KI, Young IG, Behm CA. Regulation of primary Strongyloides ratti infections in mice: a role for interleukin-5. Immunology. 1998;95(3):488–93.PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Guo X, Qiu J, Tu T, Yang X, Deng L, Anders RA, et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity. 2014;40(1):25–39.PubMedCentralCrossRefPubMed Guo X, Qiu J, Tu T, Yang X, Deng L, Anders RA, et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity. 2014;40(1):25–39.PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Mitsui T, Fukatsu K, Yanagawa M, Amenomori S, Ogawa E, Fukuda T, et al. Truncal vagotomy temporarily decreases the pro- and anti-inflammatory cytokine levels in the small intestine. Surg Today. 2014;44(6):1123–7.CrossRefPubMed Mitsui T, Fukatsu K, Yanagawa M, Amenomori S, Ogawa E, Fukuda T, et al. Truncal vagotomy temporarily decreases the pro- and anti-inflammatory cytokine levels in the small intestine. Surg Today. 2014;44(6):1123–7.CrossRefPubMed
25.
Zurück zum Zitat Diepenhorst GM, van Ruler O, Besselink MG, van Santvoort HC, Wijnandts PR, Renooij W, et al. Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: a randomized controlled trial. Shock. 2011;35(1):9–16.CrossRefPubMed Diepenhorst GM, van Ruler O, Besselink MG, van Santvoort HC, Wijnandts PR, Renooij W, et al. Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: a randomized controlled trial. Shock. 2011;35(1):9–16.CrossRefPubMed
Metadaten
Titel
Probiotics inhibit immune fluctuation in the intestinal mucous layer in rats
verfasst von
Tian weijun
Zhang teng
Publikationsdatum
01.12.2015
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 12/2015
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-015-1123-5

Weitere Artikel der Ausgabe 12/2015

Surgery Today 12/2015 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 49 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Diabetestechnologie für alle?

15.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Eine verbesserte Stoffwechseleinstellung und höhere Lebensqualität – Diabetestechnologien sollen den Alltag der Patienten erleichtern. Dass CGM, AID & Co. bei Typ-1-Diabetes helfen, ist belegt. Bei Typ-2 gestaltet sich die Sache komplizierter.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.